Sales of generic oncology drugs surge
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
List view / Grid view
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
The role of personalised and precision medicine may be ideal for the treatment of cancer, but questions about consequences and society issues still remain...
A study has reported that almost 40 percent of patients with non-surgically treatable tumours were effectively treated using a genetically modified virus...
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK...
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer...
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages...
A trial has shown that radiotherapy is more effective when levels of ropidoxuridine in a patients' body reach a certain level...
The antibody ZW25 can bind two distinct regions of the HER2 receptor to block the growth of cancer cells and has shown signs of anti-tumour activity...
Medical cannabis is now avaliable through the NHS, but many are warning about its drawbacks and that it won't be available for those who need it...
A study trialling a short course of trastuzumab in HER2 positive breast cancer patients showed that it is as effective and cheaper than a longer course...
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion...
A research team from The University of Pennsylvania have analysed the genomic effect of a cancer drug currently in clinical trials...
A cancer vaccine platform could improve the efficacy of oncolytic viruses used in cancer treatment, as shown through a study by Helsinki researchers...